Format
Items per page
Sort by

Send to:

Choose Destination

Links from Books

Items: 1 to 20 of 93

1.

Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.

Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM.

Ann Intern Med. 2009 Jan 20;150(2):65-72.

2.

Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.

de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le Cessie S, Gussekloo J.

BMJ. 2009 Jan 8;338:a3083. doi: 10.1136/bmj.a3083.

3.

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.

Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR.

Circulation. 2008 Nov 25;118(22):2243-51, 4p following 2251. doi: 10.1161/CIRCULATIONAHA.108.814251. Epub 2008 Nov 9.

4.

Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: a prospective study in 716 patients over 8 years.

Becker A, Leber AW, Becker C, von Ziegler F, Tittus J, Schroeder I, Steinbeck G, Knez A.

BMC Cardiovasc Disord. 2008 Oct 10;8:27. doi: 10.1186/1471-2261-8-27.

5.

Importance of a patient's personal health history on assessments of future risk of coronary heart disease.

Mainous AG 3rd, Everett CJ, Player MS, King DE, Diaz VA.

J Am Board Fam Med. 2008 Sep-Oct;21(5):408-13. doi: 10.3122/jabfm.2008.05.080046.

6.

Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age.

Scheltens T, Verschuren WM, Boshuizen HC, Hoes AW, Zuithoff NP, Bots ML, Grobbee DE.

Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):562-6. doi: 10.1097/HJR.0b013e3283063a65.

PMID:
18756178
7.

Prediction of first events of coronary heart disease and stroke with consideration of adiposity.

Wilson PW, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL.

Circulation. 2008 Jul 8;118(2):124-30. doi: 10.1161/CIRCULATIONAHA.108.772962.

8.

Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register.

Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson PM, Gudbjörnsdottir S; Swedish National Diabetes Register.

Diabetes Care. 2008 Oct;31(10):2038-43. doi: 10.2337/dc08-0662. Epub 2008 Jun 30.

9.

Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study.

Elkeles RS, Godsland IF, Feher MD, Rubens MB, Roughton M, Nugara F, Humphries SE, Richmond W, Flather MD; PREDICT Study Group.

Eur Heart J. 2008 Sep;29(18):2244-51. doi: 10.1093/eurheartj/ehn279. Epub 2008 Jun 23.

10.

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P.

BMJ. 2008 Jun 28;336(7659):1475-82. doi: 10.1136/bmj.39609.449676.25. Epub 2008 Jun 23.

11.

Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?

Simmons RK, Sharp S, Boekholdt SM, Sargeant LA, Khaw KT, Wareham NJ, Griffin SJ.

Arch Intern Med. 2008 Jun 9;168(11):1209-16. doi: 10.1001/archinte.168.11.1209.

PMID:
18541829
12.

Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study.

Assmann G, Schulte H, Seedorf U.

Int J Obes (Lond). 2008 May;32 Suppl 2:S11-6. doi: 10.1038/ijo.2008.29.

PMID:
18469834
13.

Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort.

Vergnaud AC, Bertrais S, Galan P, Hercberg S, Czernichow S.

Prev Med. 2008 Jul;47(1):61-5. doi: 10.1016/j.ypmed.2008.02.023. Epub 2008 Mar 10.

PMID:
18456313
14.

Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort.

Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM.

Lancet. 2008 Mar 15;371(9616):923-31. doi: 10.1016/S0140-6736(08)60418-3.

15.

Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus.

Yang X, So WY, Kong AP, Ma RC, Ko GT, Ho CS, Lam CW, Cockram CS, Chan JC, Tong PC.

Am J Cardiol. 2008 Mar 1;101(5):596-601. doi: 10.1016/j.amjcard.2007.10.019. Epub 2007 Dec 21.

PMID:
18308005
16.

Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.

Carty CL, Cushman M, Jones D, Lange LA, Hindorff LA, Rice K, Jenny NS, Durda JP, Walston J, Carlson CS, Nickerson D, Tracy RP, Reiner AP.

Thromb Haemost. 2008 Feb;99(2):388-95. doi: 10.1160/TH07-08-0523.

PMID:
18278190
17.

General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB.

Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.

18.

Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals.

Becker A, Leber A, Becker C, Knez A.

Am Heart J. 2008 Jan;155(1):154-60. Epub 2007 Oct 17.

PMID:
18082507
19.

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study.

Assmann G, Schulte H, Cullen P, Seedorf U.

Eur J Clin Invest. 2007 Dec;37(12):925-32.

PMID:
18036028
20.

Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up.

Vaidya D, Yanek LR, Moy TF, Pearson TA, Becker LC, Becker DM.

Am J Cardiol. 2007 Nov 1;100(9):1410-5. Epub 2007 Aug 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk